| Cold tumors: a therapeutic challenge for immunotherapy P Bonaventura, T Shekarian, V Alcazer, J Valladeau-Guilemond, ... Frontiers in immunology 10, 168, 2019 | 1078 | 2019 |
| Zinc and its role in immunity and inflammation P Bonaventura, G Benedetti, F Albarède, P Miossec Autoimmunity reviews 14 (4), 277-285, 2015 | 892 | 2015 |
| Medical applications of Cu, Zn, and S isotope effects F Albarede, P Télouk, V Balter, VP Bondanese, E Albalat, P Oger, ... Metallomics 8 (10), 1056-1070, 2016 | 89 | 2016 |
| Human endogenous retroviruses (HERVs): shaping the innate immune response in cancers V Alcazer, P Bonaventura, S Depil Cancers 12 (3), 610, 2020 | 63 | 2020 |
| Identification of shared tumor epitopes from endogenous retroviruses inducing high-avidity cytotoxic T cells for cancer immunotherapy P Bonaventura, V Alcazer, V Mutez, L Tonon, J Martin, N Chuvin, E Michel, ... Science Advances 8 (4), eabj3671, 2022 | 61 | 2022 |
| Differential effects of TNF-α and IL-1β on the control of metal metabolism and cadmium-induced cell death in chronic inflammation P Bonaventura, A Lamboux, F Albarede, P Miossec PLoS One 13 (5), e0196285, 2018 | 46 | 2018 |
| A feedback loop between inflammation and Zn uptake P Bonaventura, A Lamboux, F Albarede, P Miossec PLoS One 11 (2), e0147146, 2016 | 37 | 2016 |
| Protective effect of low dose intra-articular cadmium on inflammation and joint destruction in arthritis P Bonaventura, G Courbon, A Lamboux, F Lavocat, H Marotte, F Albarède, ... Scientific reports 7 (1), 2415, 2017 | 32 | 2017 |
| Neoepitopes-based vaccines: challenges and perspectives V Alcazer, P Bonaventura, L Tonon, S Wittmann, C Caux, S Depil European Journal of Cancer 108, 55-60, 2019 | 30 | 2019 |
| IL-17A and TNF-α increase the expression of the antiapoptotic adhesion molecule amigo-2 in arthritis synoviocytes G Benedetti, P Bonaventura, F Lavocat, P Miossec Frontiers in Immunology 7, 254, 2016 | 25 | 2016 |
| Regulatory effects of zinc on cadmium-induced cytotoxicity in chronic inflammation P Bonaventura, A Lamboux, F Albarède, P Miossec PLoS One 12 (7), e0180879, 2017 | 19 | 2017 |
| HERVs characterize normal and leukemia stem cells and represent a source of shared epitopes for cancer immunotherapy V Alcazer, P Bonaventura, L Tonon, E Michel, V Mutez, C Fabres, ... American journal of hematology 97 (9), 1200-1214, 2022 | 18 | 2022 |
| Tumour burden and antigen-specific T cell magnitude represent major parameters for clinical response to cancer vaccine and TCR-engineered T cell therapy M Mallet, RE Boulos, V Alcazer, P Bonaventura, Y Estornes, N Chuvin, ... European Journal of Cancer 171, 96-105, 2022 | 5 | 2022 |
| Cancer vaccines: what’s next? S Depil, P Bonaventura, V Alcazer Oncotarget 10 (40), 3985, 2019 | 4 | 2019 |
| Nouvelles approches vaccinales en cancérologie S Depil, P Bonaventura, V Alcazer, L Tonon Bulletin du Cancer 105, S113-S120, 2018 | 1 | 2018 |
| Changement de l’homéostasie du Zinc et du Cadmium par l’inflammation chronique et nouvelles options thérapeutiques pour le traitement de l’arthrite P Bonaventura Lyon, 2016 | 1 | 2016 |
| HERV-derived epitopes represent new targets for T-cell based immunotherapies in ovarian cancer P Bonaventura, O Tabone, Y Estornes, A Page, V Mutez, M Delles, ... bioRxiv, 2024.07. 13.603392, 2024 | | 2024 |
| Targeting a shared neoepitope derived from non-canonical translation of c-MYC oncogene in cancer cells E Baulu, A Bolon, E Etchegaray, F Raimundo, A Merienne, J Martin, ... bioRxiv, 2024.05. 23.595486, 2024 | | 2024 |
| Human Endogenous Retroviruses represent a source of shared tumor epitopes inducing high-avidity cytotoxic T cells for cancer immunotherapy. P Bonaventura, V Alcazer, V Mutez, L Tonon, J Martin, N Chuvin, E Michel, ... CANCER IMMUNOLOGY RESEARCH 10 (12), 2022 | | 2022 |
| Abstract B49: Human Endogenous Retroviruses represent a source of shared tumor epitopes inducing high-avidity cytotoxic T cells for cancer immunotherapy P Bonaventura, V Alcazer, V Mutez, L Tonon, J Martin, N Chuvin, E Michel, ... Cancer Immunology Research 10 (12_Supplement), B49-B49, 2022 | | 2022 |
